Turf War ?

protectingturf

Have you ever encountered a animal who is overly protective of something… their yard, their food, a stuffed animal or their “toy”.  We Homo sapiens can exhibit aggression of protecting our “turf” or trying to gain turf … which exhibits itself as GREED. With all too many of us living beyond our means… protecting one’s livelihood forces some who would not otherwise be offensive or defensive to protect their livelihood and life style.

IMO.. the war on drugs is a perfect example of this concept. The Harrison Narcotic Act 1914 basically created the “black market” for MJ, Cocaine, Heroin. That black market was allowed to mature until 1970 when Congress and Pres Nixon declared war on this black market that Congress had created with the creation of the Bureau of Narcotics and Dangerous Drugs (BNDD) which evolved into the DEA a few years later. Initially there is abt 1500 employees at the Federal level.

In the early 70’s Congress made the robbing or holding up a pharmacy and stealing controlled substances became a felony .. just like robbing a bank.. which brings the FBI into the crimes against a pharmacy when controlled substances are involved.

In the mid-80’s the privatization of federal prison began when the publicly for profit company Correction Corporation of America was awarded the contract to run the Hamilton County, TN facility.  This put in place a for-profit company who began lobbying Congress for increased penalties for non-violent offenders – like drug abuse/addiction.

Next in the mid-90’s, KY was the first state to implement a Prescription Monitoring Program, to help law enforcement to further try and uncover those that appear to be addiction or diversion of controlled substances.

Today, we have all states with a PMP law on the books, with the exception of MO, but there are only some 40 odd states with a operational PMP.

Back in 1914, along with the Harrison Narcotic Act… the court system determined that the mental health disease of addiction when Cocaine, Heroin and MJ were involved.. was a crime. With a population of abt 100 million that would mean that there was a estimated 1-2 million people with addictive personalities and thus potentially becoming criminals within the new court edict.

Today, we have nearly half of the states that have authorized the personal use (decriminalized) of either MJ or MMJ.. As is the state’s right under the Tenth Amendment of our Constitution.  The Administration has instructed the DEA to “back off ” the enforcement of MJ/MMJ laws at the state level. Clearly, loosing this area of enforcement could put a dent into the DEA’s budget and staffing levels…

So as the DEA has increased their “enforcement” on prescriber, pharmacies/Pharmacists, wholesalers… result it would seem is more people using/abusing/dying from Heroin,, robbing and breaking into pharmacies. The result is that the DOJ/FBI/DEA have more people who are now criminals and justification for maintaining and/or asking Congress for larger budget and larger staffing levels to deal with this increase in criminal activity.

However, if Congress in 1914 had not created this “black market” and had not defined addiction to opiates was a crime… and we treated those who suffer from the mental health disease of addiction… there would be no black market.. there would be no need for a war on drugs and there would be no need for the DEA to exist.

There would be no need to deny chronic pain pts their medically necessary medication. How many fewer “accidental overdoses” and/or undocumented suicides would there be… how many lives could be saved. Could the DEA, in pursuing their self-centered need to exist … be indirectly causing tens of thousands of deaths every year ?

I doubt if our Founding Fathers meant for “We the People” to apply to a few thousand government employee protecting their job, livelihood and life style ?

Sued because they are a wholesaler selling a legal product ?

Federal court sides with insurer in ‘pill mill’ lawsuit

http://wvrecord.com/news/273052-federal-court-sides-with-insurer-in-pill-mill-lawsuit

MIAMI – A federal court ruled earlier this week that an insurer does not have to defend and indemnify its client, one of more than a dozen major prescription drug distributors that was sued by former West Virginia Attorney General Darrell McGraw in 2012.

pills&bottleMcGraw filed two lawsuits in Boone County Circuit Court in January 2012 against 14 out-of-state drug distributors “for their roles in creating and profiting” from a “prescription drug epidemic.

At the time, the Centers for Disease Control listed West Virginia as the nation’s most-medicated state, filling nearly seven more prescriptions per person annually than the national average.

McGraw argued the distributors are a “major scourge” in West Virginia, costing the state $430 million to $695 million annually and burdening its hospitals, courts and law enforcement.

Prior to the underlying lawsuit, Gemini Insurance Co. issued Florida-based Anda Inc. – one of the distributors McGraw sued – an insurance policy.

However, Gemini argues it has no duty to defend and indemnify its client. It filed a motion for summary judgment in the U.S. District Court for the Southern District of Florida.

On Monday, the federal court granted Gemini’s motion, ruling that coverage was not implicated because the attorney general’s lawsuit was for economic damages, not for “bodily injury,” seeing as there were no claims by the individual citizens of West Virginia.

“Key to the conceptualization of the Underlying Complaint is West Virginia’s theory of relief — the State seeks relief solely for its own economic loss and not for any individual claims the persons harmed directly by the prescription drugs might assert,” wrote Judge K. Michael Moore in his 18-page omnibus order.

“The Underlying Complaint makes clear that the claims asserted are for ‘costs to the State of West Virginia’ incurred as a result of the prescription drug abuse epidemic.

“Any reference to the drug abuse and physical harm to West Virginia citizens merely provides context explaining the economic loss to the State.”

The federal court also ruled that the policy’s antitrust/unfair competition exclusion applied.

Chicago-based law firm Hinshaw & Culbertson LLP represented Gemini in the coverage dispute.

According to media reports, Boone Circuit Judge William Thompson ruled in December that the case against the distributors can proceed. The companies had asked for the case to be dismissed.

This entry was posted in Federal Court, News, State Attorney General and tagged , , , , , . Bookmark the permalink.
It is hard to imagine that a company providing a legal product… as a wholesaler.. not as a manufacturer.. in our free market, capitalistic society.. and the insurer of the company was able to “wiggle out” of its legal obligation to defend and  indemnify its client.  The same client that it more than willingly to collect premiums from for said insurance.
Is this another horrid example of that puritanical thread in our societal fabric that keep rearing its ugly head… much like this administration’s OPERATION CHOKE POINT by our DOJ.  Going after legally licensed companies, selling legal products that the DOJ has determined to be morally troublesome.

22 Veterans commit suicide EVERY DAY

vakillingIt would appear that our news media must consider the innocent lives of those that are killed my ISIS in the middle east are much more important and have a higher (news) value than the 22 veterans that commit suicides (on average) every day.  Collectively, we have some 40, 000 people commit suicide every year.. about THREE TIMES the number that die from drug overdoses.. yet how many times have you read about all those suicides as opposed to how many times that you hear about deaths from drug overdoses ? I guess our society’s moral compass more quickly points toward murders than suicides. While both are illegal.. how does our justice system justify its existence with suicides.. who do you throw into jail… have to hire an attorney and who is the prosecutor going to charge and take to court ? Maybe the body resulting from a suicide can generate only so much media attention.. unless that body had drugs in their system and our judicial system has someone to blame and our judicial system can “go after” .. the person that sold or otherwise made the drugs available.

Is “To fill or not to fill” a rhetorical question ?

magic8ballI as seeing a larger and larger picture evolve.. as pieces of this war on drugs/pts comes into focus..  I spent a large portion of my day with Staywell ( FL Medicaid) trying to help a pt getting their meds  in the system..  Most of the staff at Staywell seemed to be pretty well trained to express empathy for the pt’s plight.. However, they obviously haven’t been granted any authority to help resolve a problem.. So I guess that empathy expressed without any action.. is a pretty hollow gesture.

The investigative reporter (Darsey Spears) from channel 13 in Las Vegas just did her second report this year… and has tried to gets answers from the major chains, DEA, and this time bureaucrats. The impression from the responses from the NV Federal bureaucrats.. IMO.. a lot of “I want to care”… ” I don’t want to know about it”.. “I will get back with you .. if you contact me several times in the next year or two”

Matt Grant at channel 2 in Orlando … has done several articles.. Gov Scott, AG Bondi and the local DEA special agent did a lot of finger pointing… the local Orlando Pharmacist that spoke to Matt Grant his independent pharmacy has since been visited by the DEA..

It is becoming more obvious me that bureaucrats, politicians, wholesalers, judicial system, corporate pharmacy, and others .. are perfectly happy  with the status quo and have no valid intentions of moving from that point.

BUT,,, all of these entities have one thing in common – FEAR … yes that FOUR LETTER “F” WORD !

You just have to listen to what they each say individually…

Pharmacists routinely profess that they are declining filling controlled Rxs for fear of losing their license and their livelihood..  which boils down to MONEY… sue the individual pharmacist and they will lose MONEY… the more pts that sues them… the more MONEY they will lose.. They can keep their license but their financial quality of life … could take a seriously hit.

The pharmacy corporation FEARS losing money and their stock price falling.. apparently more and more people are spending money with them.. from the financial reports that they make public.. but .. imagine the bad PR that could be generated by pt who could be turned down.. making factual posts on their website and/or send out tweets with #their name…  Trust me… they scan the web.. watching for what is said about them on the web.

Videoing their Pharmacists as they make unsavory statements about you or our prescriber…

There has got to be more than just Matt Grant and Darsey Spears have a concern about pts not getting their meds.. they claim that there are 116 million chronic pain pts.. that doesn’t count all those others with subjective diseases that requires treatment with a controlled med. Pick up the link to these investigative stories and send them to the investigative reporter in your area … and ask why they are not concerned about chronic pain pts being denied their medications.

You can believe the promises and platitudes of these various entities.. how long are you going to accept these worthless, hollow words ?

I am receiving emails from more and more pts that are being cut off of their meds from pharmacies that they have patronized for years..  IMO.. it is not if you lose access to your meds… but.. when you lose access to your meds.

 

First they came for the mentally ill addicts, and I did not speak out—
Because I was not a mentally ill addict.

Then they came for the empathetic prescribers, and I did not speak out—
Because I was not a empathetic prescriber.

Then they came for the Pharmacists, and I did not speak out—
Because I was not a Pharmacist.

Then they came for me—and there was no one left to speak for me

Another TV report about Federal bureaucrats that don’t know or don’t care ?

Patients caught in middle of war on prescription drug abuse

http://www.jrn.com/ktnv/news/contact-13/contact-13-investigates/Pain-at-the-pharmacy-295812391.html

By Darcy Spears. CREATED Mar 10, 2015

Las Vegas, NV (KTNV) — Contact 13 is seeing an overwhelming response after our recent investigation exposing how some pharmacies are profiling patients.

A former pharmacy insider said customers are often denied pain medication based on their looks. They’re caught in the middle of a war on prescription drug abuse.

Since no one at the major pharmacy chains is stepping up to answer our questions, Contact 13 is taking the issue back to lawmakers.

“When I saw it first air, it hit home hard,” Aaron Gilliam feared he was alone until he saw our latest story. “Profiling people, I just don’t feel is fair at all.”

Aaron’s path of pain started in 2006 when he fell 45-feet from an overpass.

“My legs hit first. It took a little bit of the spring but then my tailbone just hit real hard so everything compressed.”

He’s had 14 operations to fix the damage.

“That is the thoracic area with the rods and screws and that’s the bridge vertebrae,” Aaron explained as he showed his x-rays of a spine rebuilt with stuff that looks like industrial building materials.

The pain continues to make Aaron sick, “On a scale of 1 to 10, it’s like going on 15, 20.”

So, like many who suffer from a serious injury, Aaron needs strong pain pills to make things manageable. But he’s running into the same roadblocks Contact 13 started investigating more than a year ago.

We’ve received email and phone calls from hundreds of patients complaining about pharmacists who refuse to fill prescriptions for pain meds.

Some patients are told they don’t meet a new criteria, and there’s talk about limits imposed by the DEA and a secret checklist.

Most often customers are turned away, told by pharmacies that they’re out of the meds patients need.

“So you end up blowing, like one day I wasted 250 miles on my truck and 24 gallons of gas trying to drive around getting it. And still no result,” said Aaron.

We also met with Wanetta Naki, another viewer who contacted us after seeing our story about pain patients being profiled, “Oh my God. You’re kidding me. They’re actually profiling everybody. That’s not their place to do that.”

Like Aaron, Wanetta was also injured, “I was rear-ended by a tractor trailer rig which totally messed up my back.”

She’s getting the same run-around and hasn’t had her prescription for Percocet filled for months, “Now I’m having a hard time sleeping at night. There are times I can’t even climb up the stairs to go to my bedroom.”

Wanetta knows the dangers of abuse first hand. She lost a good friend who overdosed on prescription pills. But she can’t understand why legitimate patients are left in the dark.

“They should let us know out in the open, what’s going on. What is the true meaning and reason why we can’t get our pain medication?”

That’s the question Contact 13 has been asking for more than a year. We’ve taken the issue to lawmakers once again, asking them to at least open a public dialogue.

Sen. Harry Reid would not do an on-camera interview. His staff said they would provide a statement, but never did.

Sen. Heller and Rep. Mark Amodei didn’t respond at all.

Congresswoman Dina Titus is planning to meet with the DEA and executives from pharmacy chains. We’ve asked when and whether patients and doctors will be included, but we haven’t gotten an answer.

Rep. Joe Heck, who is a physician himself, said through staffers that his office hasn’t heard from care providers about this problem and they “hold no sway” over private pharmacy companies.

A spokesman for Crescent Hardy, the newest member of the Nevada delegation, listened carefully to the information we provided and said it would be seriously considered and analyzed by their team.

In the meantime, Aaron and Wanetta want decision-makers to hear their voices.

“This is actually on overreaction to the drug abuse problem,” said Wanetta.

“They should be put in our position where they feel the pain that we have,” added Aaron. “Get the run around that we have, wasting money and time trying to chase the medications down just so you can live a normal life.” 

Contact 13 is not going to stop here. We’ll continue to demand answers until someone steps up to address the problem.

If you’re being denied your medication, let us know about it.

We want to make sure lawmakers hear your voice. Contact them at the websites below:

You can find statements from pharmacy chains in our previous reports:

Patients profiled at pharmacy counters

Prescription for Pain: Change in law causes more delays, pain

Cancer patients being denied medications by pharmacists

Pharmacy checklist questioning doctor prescriptions

Pharmacy delays causing more than headaches

Prescription for Pain: Patients struggling to fill medications

Locals in need of prescription medications being turned away

Darcy Spears

Darcy Spears

Email Twitter

Darcy Spears is currently the Chief Investigative Reporter for Action News.

Not every Pharmacist is drinking the Pharma’s Kool-Aid ?

magglassHow much of pharmacy theory is really based on science?

http://drugtopics.modernmedicine.com/drug-topics/news/how-much-pharmacy-practice-really-based-science?page=0,0

The long and sometimes peculiar history of the pharmacy profession has included salves, potions, powders, tinctures, and elixirs of doubtful safety

Dennis Miller

and effectiveness. Has our profession effectively disassociated itself from the days of unproven and unsafe remedies? Some critics believe that many of the products on pharmacy shelves today are nothing more than modern versions of snake oil.

I would argue that much of pharmacy today resembles a religion far more than a science, in that religious belief requires a suspension of critical thinking and the reliance on doctrine, tradition, and authority. 

See also: What I wish I had learned in pharmacy school

Where our definitions come from

Pharmacy students are told from day 1 that pharmacy is based on science, with the double-blind placebo-controlled trial being the gold standard for determining what is true. But what if large pharmaceutical manufacturing concerns routinely massage data derived from controlled trials?

Do you believe that all the products on our shelves are indeed “safe” and “effective” as required by law? Or do you believe that the

terms “safe” and “effective” are relative?

Do you believe that the FDA’s definition of “safe” and “effective” is the same as the laymen’s definition?

Mechanism of action

When reading the pharmacology section in the official prescribing information, one is struck by how often the precise mechanism of action for so many drugs is unknown or is described in terms of speculation and conjecture. So much is unknown about drug action at the molecular and cellular levels, yet it is at those levels that drugs are active.

Take the commonly prescribed drug Xanax. The official labeling for Xanax states, “CNS agents of the 1,4 benzodiazepine class presumably exert their effects by binding at stereo specific receptors at several sites within the central nervous system. Their exact mechanism of action is unknown.”

This vast reservoir of uncertainty about cell biology and drug action doesn’t seem to discourage the pharmaceuticals industry from persistently promoting its products.

In my opinion, in light of the fact that various pharmaceutical concerns have too often suppressed and manipulated data about potential drug risks, a pharmacist is well-served by a healthy dose of on-the-job skepticism. Yet, in my experience, many pharmacists become angry when pharmaceutical products are criticized. It is almost as if someone is criticizing their religion.

See also: Drugs or lifestyle changes? Are pharmacists pill-happy?

Where’s the debate?

If pharmacists were true scientists, lively debate about the pros and cons of pharmaceuticals would be encouraged. I don’t see astronomers, physicists, and biologists getting angry when long-held assumptions in their fields are challenged, but I do often see pharmacists angered when the safety and/or effectiveness of certain popular drugs are challenged.

Pharmacy school as I remember it too often resembled a seminary in which the primary focus was molecules, cells, and chemistry, rather than health. The prevailing view was that the human body is a rickety old contraption, prone to breakdown and in need of constant shoring up with potent pharmaceuticals.

We were force-fed plenty of chemistry in pharmacy school. So when was the last time you used your extensive knowledge of chemistry in filling a prescription or in answering a question from a physician or customer?

See also: Why I wrote “Pharmacy Exposed”

An intentional mystery?

Consider this: Has there been a deliberate effort to create a mystery around the handwritten prescription?

In my opinion, an illegible prescription is part of the mystique that physicians have intentionally cultivated for themselves for centuries.

Several years ago, the FDA magazine FDA Consumer published an article stating that prescriptions were originally made up of all kinds of symbols and Latin usages to create a sense of mystery. The article stated that, in an effort to keep the knowledge of medicine and pharmacy from the general public, physicians used strange alchemic symbols to designate the materials and processes to be used in compounding medications.

The article went on to state: “The effect on the appearance of the prescription may be readily imagined,” one medical historian has written, “and it is evident that the physician succeeded perfectly in making his preparation a mystery to the patient.” Keeping the patient in the dark and creating an aura of mystery and magic are precisely the reasons given by medical historians to explain the use of Latin in prescription writing as late as 1900.

Ask any pharmacist whether he/she believes this desire to surround the prescription in mystery ended in 1900. Latin abbreviations are in common use today, even though, in most cases, an English abbreviation could be written just as quickly.

Forbidden to share information

According to another issue of FDA Consumer (March 1979, p. 12), as long as 400 years ago, English physicians were forbidden to teach their patients about medicines: “Back in 1555 England’s Royal College of Physicians advised the profession thus: ‘Let no physician teach the public about medicines or even tell them the names of medicines.’”

Admittedly, this attitude may not be confined to the professions of medicine and pharmacy. Jesse Vivian, a pharmacist, attorney, and professor at Wayne State University College of Pharmacy, has written: “Practitioners of any vocation in any sector of the universe have communication shortcuts, abbreviations, and foreign phrases or languages that are known only to those inside the occupation. In fact, there is a notion that professionals intentionally use words or phrases that are unknown to the general populace as a mechanism of keeping lay people from getting to know too much about any given profession.” (“In Pari Delicto,” U.S. Pharmacist, January 2007, p. 88)

DTC advertising

Has this time-worn practice of concealing elements of the truth from consumers continued to the present day?

Consider direct-to-consumer advertisements for prescription drugs, a practice permitted only in the United States and New Zealand.

Do you feel that prescription drug ads on TV are deceptive? It is not by coincidence that these ads often consist of images of attractive people having fun on sunny days with friends, family, and pets, while the announcer rapidly reads through a long list of scary possible side effects that can even include death.

Do you believe that these advertisements encourage the unnecessary use of prescription drugs and contribute to the overmedication of Americans?

See also: The pharmacist as author

Pathologizing human experience

The term “disorder” is appended to common human behaviors to lend legitimacy to what is, in fact, the pathologization and medicalization of the human condition. For example:

Social anxiety disorder is a $10-dollar word for shyness.

Generalized anxiety disorder is a fancy term for a broader form of shyness.

Seasonal affective disorder is a fancy term for the winter blues.

Attention-deficit hyperactivity disorder pathologizes poor school performance and/or the inability to sit still and pay attention.

Obsessive compulsive disorder now characterizes relatively common behaviors such as excessive handwashing.

Shift work sleep disorder (SWSD) refers to a circadian rhythm sleep disorder characterized by the insomnia and excessive sleepiness that affect people whose work hours overlap with the typical sleep period. Working the overnight shift would predictably have adverse consequences on one’s health, but the term shift work sleep disorder makes it sound like a medical disorder, rather than an expected consequence of abnormal sleep patterns and disruption of circadian rhythms.

Expect to hear more in the future about obsessive shopping disorder, obsessive gambling disorder, temper dysregulation disorder, and oppositional defiant disorder.

Are industry marketers so insecure about the validity of all these “diagnoses” that they feel compelled to label them “disorders” to legitimate them in the public mind?

“Brain-chemical imbalances”

Do you know that the concept of a “chemical imbalance in the brain” has never been proven? From where I sit, it looks like pure speculation, yet it is used to justify the massive prescribing of antidepressants.

Do you believe that depressed people are dealing with some depressing life circumstance (marriage problems, problems with the kids, stressful jobs, inadequate income, etc.)? Or do you believe they have a chemical imbalance in their brain?

How much of the effectiveness of antidepressants is due to the placebo effect?

Indeed, how much of the benefit from a wide range of medical treatments is due to the placebo effect?

The war on stomach acid

Do you agree with the massive war on stomach acid being conducted with H2 antagonists and proton pump inhibitors?

For hundreds of thousands of years of human evolution, stomach acid served the purpose of aiding in the digestion of foods and killing noxious organisms. Today, stomach acid is seen as pathological and an error in human physiology. Yet use of the PPIs deployed against stomach acid has been linked to a higher risk of hip fracture, pneumonia, C. diff infection, and malabsorption of magnesium, iron, or vitamin B12.

It is also worth noting that acid suppression can increase susceptibility to community-acquired pneumonia, possibly because reduction of gastric acid secretion enhances colonization of the upper gastrointestinal tract with oral bacteria.

Pathological menopause

Here’s another example of the lack of respect that modern medicine often shows Mother Nature and the long course of human evolution.

The physiology of some primates is programmed for a large decrease in estrogen production at the menopause, yet modern medicine views it as pathological. The chronicle of the massive prescribing of estrogen at menopause has not seen a happy ending. Hormone replacement therapy has led to an increase in cardiovascular disease and some cancers in many of the women who were prescribed estrogen.

Endless pills for diseases of modern civilization

Modern medicine routinely prescribes potent drugs to treat such diseases of modern civilization as hypertension, type 2 diabetes, elevated cholesterol, etc.

The Merck Manual (16th edition, p. 984) says that most cases of hypertension and type 2 diabetes are preventable: “Thus weight reduction will lower the BP [blood pressure] of most hypertensives, often to normal levels, and will allow 75% of type 2 diabetics to discontinue medication.” Ninety percent of diabetics have diagnoses that fall under the heading of type 2.

Modern medicine prefers to use pills to treat obesity rather than provide lifestyle education about the importance of pushing oneself away from the kitchen table.

In your observation, how effective have obesity pills been in enabling patients to keep weight off long-term?

Cancer treatment vs. cancer prevention

Our environment is filled with synthetic chemicals never seen on the face of the earth before the last few generations.

Do you believe that most cancers could be prevented if we focused on our exposure to these agents? Or are you completely happy with modern medicine’s focus on chemotherapy rather than on prevention?

The Merck Manual (17th edition, pp. 2591-2592) essentially states that up to 90% of cancer is preventable: “Environmental or nutritional factors probably account for up to 90% of human cancers. These factors include smoking; diet; and exposure to sunlight, chemicals, and drugs. Genetic, viral, and radiation factors may cause the rest.”

Are Americans grossly overmedicated?

Modern medicine has a pill for every ill, despite the fact that many of those pills don’t do much to improve those ills.

How effective do you consider drugs that treat osteoporosis, psychosis, and Alzheimer’s?

Are you troubled by the very common diagnoses of ADHD and depression in kids?

Are you troubled by the widespread use of antibiotics for conditions like the common cold?

Are you troubled by the routine pharmaceutical treatment of mild-to-moderate fever, despite strong evidence that fever fights off invading organisms?

In my opinion, modern medicine and pharmacy are often spellbound by certain wildly popular therapies that are destined to come crashing back to reality. For example, hormone replacement therapy flew high in the sky for several decades before ignominiously falling back to earth.

Are we in a similar hype-induced bubble with the massive prescribing of statins? Cholesterol is needed for the proper functioning of every cell in the human body, yet modern medicine views cholesterol as yet another pathology.

Drugs vs. lifestyle changes

What would happen if drug studies routinely compared drugs to lifestyle changes?

Do you trust the results of studies of drug safety and effectiveness sponsored manufacturers of pharmaceuticals?

Drug studies are carried out in subjects (often paid volunteers or prison inmates) who are usually much healthier and younger than the target population for these drugs in the real world.

In drug trials, concomitant diseases are viewed as complicating factors, whereas in the real world, the people who are prescribed these drugs very often have multiple conditions.

Drug studies routinely compare Drug A to placebo. Why not compare Drug A to Drug B? Why not compare Drug A to lifestyle changes? Why not compare Drug A to dietary changes? Why not compare Drug A to exercise? Why not compare Drug A to weight loss?

Louisville cardiologist John Mandrola, MD, thinks statins are prescribed too readily and that lifestyle approaches would be more effective. He says cardiologists get inferior results compared to those seen by physical trainers and nutritionists. In an article titled “Heart Disease and Lifestyle: Why Are Doctors in Denial?” (Medscape, Jan 12, 2015), Dr. Mandrola wrote:

In a randomized controlled trial of primary prevention, no cardiologist would want to be compared against a good physical trainer or nutritionist. We would get trounced. …The study would be terminated early due to obvious superiority of lifestyle coaching over doctoring….

It’s the same story at medical meetings: Sessions on drugs and procedures draw the crowds. Late-breaking studies rarely involve the role of exercise or eating well. Exercise, diet, and going to bed on time have no corporate backing.

…I believe the collective denial of lifestyle disease is the reason cardiology is in an innovation rut.

…This is how I see modern cardiology. Our tricks can no longer overcome eating too much and moving too little.

…In fact, a reasonable person could make an argument that our pills and procedures might be making patients sicker.

Think about it

In summary, do you feel that pharmacy is primarily based on science?

Or do you feel that we are still very much in an era of unproven and unscientific therapies, manipulated studies, wishful thinking, and pure hype?

There are fewer pharmacy superstars (insulin, antibiotics, morphine, thyroid hormone, etc.) than the public assumes.

What are your candidates for the most effective — and least effective — drugs in the pharmacy?

Which drugs are you most proud to dispense? Which ones would you never take yourself?

Which drugs are you embarrassed to see sitting on pharmacy shelves in the 21st century?

Recommended reading:

1. James LeFanu, MD, The Rise and Fall of Modern Medicine (New York: Carroll & Graf Publishers, Inc., 1999)

2. Marcia Angell, MD, The Truth About the Drug Companies (New York: Random House, 2004)

3. John Abramson, MD, Overdosed America (New York: HarperCollins Publishers Inc., 2004)

4. Stephen Fried, Bitter Pills (New York: Bantam Books, 1998)

5. Thomas J Moore, Prescription for Disaster (New York: Simon & Schuster, 1998)

6. Armon Neel, PharmD, Are Your Prescriptions Killing You? (New York: Atria Books—Simon & Schuster, 2012)

7. Melody Petersen, Our Daily Meds (New York: Sarah Crichton Books—Farrar, Straus & Giroux, 2008)

8. Jerry Avorn, MD, Powerful Medicines (New York: Alfred A. Knopf, 2004)

9. Greg Critser, Generation Rx (Boston: Houghton Mifflin Company, 2005)

Dennis Miller is a retired pharmacist living in Delray Beach, Fla. He is the author of two books (Pharmacy Exposed and Chain Drug Stores Are Dangerous), both available at Amazon.com. He welcomes feedback at dmiller1952@aol.com.

pahrmacy exposed

dennismillerbook2

FDA blames DEA… DEA blames FDA and pts continue to suffer

DEA Contributes to Shortages of Drugs With Controlled Substances: Report

http://blogs.wsj.com/pharmalot/2015/03/11/dea-contributes-to-shortages-of-drugs-with-controlled-substances-report/

Over the past decade, there has been a noticeable shortage of prescription drugs containing controlled substances, such as narcotics and stimulants, causing difficulties for both patients and physicians. Doctors have to scramble to find alternatives and, sometimes, patients simply go without treatment. As it so happens, a new report finds the U.S. Drug Enforcement Agency has contributed to the problem.

How is this possible? Well, controlled substances are regulated by DEA, because of the potential for abuse and addiction. And to prevent diversion, the DEA sets quotas that limit the amount that can be produced. The DEA, however, has not effectively managed the quota process and this has contributed to product shortages, according to the U.S. Government Accountability Office.

“Each year, manufacturers apply to [the] DEA for quotas needed to make their drugs,” the GAO writes in its report. The “DEA, however, has not responded to [the drug makers] within the timeframes required by its regulations for any year from 2001 through 2014… Manufacturers who reported quota-related shortages cited late quota decisions as causing or exacerbating shortages of their drugs.”

For its part, the DEA disputed some of the findings and also argued that some of the problems stem from disagreements with the FDA, notably, that the two agencies have differing views on how to define prescription drug shortages.

Concerns about the DEA were raised three years ago by two U.S. Senators – Chuck Grassley (R-Iowa) and Sheldon Whitehouse (D-R.I.) – who wrote the GAO and asked the agency to conduct a study about the extent to which the DEA was contributing to shortages of controlled substances. At the time, there were a rising number of prescription drug shortages.

In its report, the GAO noted that, of the 168 shortages of controlled substances that were reported from January 2001 through June 2013, nearly 70% began between 2008 and 2013. About half of these were pain relievers and most were generics. As we have noted previously, shortages have sometimes been blamed on FDA enforcement of quality-control problems or manufacturers existing markets.

The GAO, however, says the DEA has played a role. The DEA has “weak internal controls” that jeopardize its ability to manage quotas, according to the GAO. As an example, the GAO noted that DEA officials acknowledged quality-control checks are not performed to verify the accuracy of data contained in year-end reports. The GAO estimates that 44% of records in 2011 and 10% of records in 2012 had errors.

What other problems exist? The GAO found the DEA does not have metrics – and data is not monitored – to assess its own performance. Moreover, the DEA lacks protocols, policies and training materials for managing quotas. As a result, the DEA “does not have reasonable assurance that the quotas it sets are in accordance with its requirements.”

There is another issue – the DEA and the FDA are at odds. Although the agencies are required to coordinate when combating shortages of prescription drugs containing controlled substances, the GAO finds they do not have a “sufficiently collaborative relationship.” Notably, the agencies “disagree about what constitutes a shortage,” the GAO writes.

Consider this GAO observation: “DEA officials also said that they do not believe FDA appropriately validates or investigates the shortage information it posts on its website and that posting this information encourages manufacturers to falsely report shortages to obtain additional quota. However, FDA reports that it takes steps to investigate and confirm the shortages on its website.”

As for a fix, the GAO recommends the DEA should institute metrics and policies and perform periodic data checks in order to better manage the quota process. The GAO also suggests the DEA and FDA should “quickly update” a memorandum of understanding, which has not been revised since the 1970s, so that information can be more easily shared and agreed-upon steps taken to combat shortages.

In a brief response, the U.S. Department of Health & Human Services, which oversees the FDA, agreed that the memorandum should be updated and says it is “actively working” with the DEA to do so. The DEA, however, offered a much lengthier response in which the agency neither agreed nor disagreed with the recommendations, but did raise numerous objections to the GAO report.

For instance, the DEA argued that the GAO does not understand how quotas are established and maintained that it has no control over manufacturer decisions. The DEA also disputed how the GAO defined shortages and complained that a draft report noted there was no “causal relationship” between shortages and DEA procedures for establishing quotas. The GAO rebuffed the criticisms.

This is a lengthy report and worth reading, so take a look here.

I thought the war on drugs was suppose to keep illegal drugs off the street ?

Local DEA office reports 15 have died so far in 2015 from heroin overdoses

http://www.buffalonews.com/city-region/local-dea-office-reports-15-have-died-so-far-in-2015-from-heroin-overdoses-20150311

U.S. Attorney William J. Hochul Jr. said the arrest of John Haak and Francis Tessina underscores the dangers of the heroin and fentanyl-laced heroin being sold on the streets of Western New York.

Hochul, who has made a point of publicly issuing warnings about heroin, displayed a box of rat poison and suggested the heroin being bought by addicts is all too often fatal.

“You’re doing almost the same thing as injecting yourself with rat poison,” he said Wednesday.

Haak and Tessina appeared Wednesday before U.S. Magistrate Judge Jeremiah McCarthy.

Powerful pills from local Wisconsin VA showing up on the street, police say

Powerful pills from local Wisconsin VA showing up on the street, police say

http://www.foxnews.com/politics/2015/03/10/powerful-pills-from-local-wisconsin-va-showing-up-on-street-police-say/

Jason Bishop, a former patient at the Veterans Affairs facility in Tomah, Wis., says doctors there pushed drugs on him as a solution to virtually all his problems.

“They would want you to take more drugs instead of finding something that would work. They would just give you something to basically say, ‘shut up,’” Bishop said. He disliked returning for treatment because the sight of fellow veterans lining the hallways with “empty eyes” depressed him.

“They’re breeding drug addicts,” Bishop said.

Bishop’s claim is now backed up by two reviews. The latest, released March 10, found unsafe practices at the Tomah VA in pain management and psychiatric care. The review found extensive use of opioids (synthetic opiates) and benzodiazepines (tranquilizers). The report also found no evidence that prescriptions were changed if patients hurt themselves by falling or displayed “aberrant behaviors.”

Patients were two and a half times more likely than the national average to be prescribed a high dose of morphine. Tomah was double the national average when it came to the risky practice of using opioids and benzodiazepines at the same time.

However, the pill problem doesn’t end in the Tomah, Wis., VA. Some say those overprescribed pills were also ending up on the street.

Mark Nicholson, police chief in Tomah, said powerful, taxpayer-funded meds have been showing up in busts.

“We can tell they are from the VA, either because the person tells us or we can see that they are in the pill bottles from the VA,” Nicholson said.

The pill problem was first documented in the IG report, completed in March 2014. That report was kept from the public until Wisconsin Democratic Sen. Tammy Baldwin’s office forced the publication through the Freedom of Information Act.

It summarized that the Tomah VA was prescribing an “unusually high opioid amount,” and had a pattern of refilling prescriptions for powerful drugs early.

Patients who did not take their meds also were getting prescriptions refilled.

“We substantiated the allegation that negative urine drug screens (UDS) are not acted on and that controlled substances are still prescribed in the face of a negative UDS,” reads the report.

This pattern could well be tied to what people like Nicholson are seeing.

Cops call it a ‘diversion’ when prescribed drugs are not used for their intended treatment.

And a source within the DEA confirms that federal agents are examining the flow of drugs around the Tomah VA.

Whistleblowers had been complaining for years about problems at the Tomah VA. However, the latest review concludes they were subject to a culture of fear at the VA. Even for those who chose to speak up, progress has been slow.

The investigation by the OIG took two-and-a-half years. The end result was an 11-page report, containing some startling facts but few conclusions. Now, some people in powerful positions have taken notice – including Sens. Baldwin and Ron Johnson, R-Wis., as well as U.S. Rep. Ron Kind, D-Wis. VA Secretary Robert McDonald has called for a comprehensive review of medication practices in Tomah. 

Bishop said you don’t need a skilled investigator to spot drug abuse at the VA.

“You could tell who was just there for the medication, because they were just so keyed in on the medication. It had nothing to do with getting better,” he said. “It had nothing to do with finding what was wrong. It was all about renewing my prescription.”

Nicholson said the recent attention, though, has not done anything to abate the flow of drugs from the VA.

“I don’t think we’ve seen any change as to the volume of drugs that we are coming across on the street level,” he said.

A former secretary at the VA, Ryan Honl, has emerged as a primary whistleblower in Tomah. He charges the overuse of drugs had been motivated by the former chief of staff at the hospital, Dr. David Houlihan. Bishop echoes that claim.

The father of former U.S. Marine Jason Simcakoski, who died of mixed drug toxicity while in the care of the Tomah VA, also told Fox News the problems trace back to Houlihan.

Houlihan is now the subject of two separate investigations by the Wisconsin Department of Safety and Professional Service. One complains that he was overprescribing oxycodone. The other cites at least 11 allegations tied to overprescribing, with suspicions that the practice led to at least one patient’s death.

Bill would allow pharmacists to refuse to dispense abortion meds

Bill would allow pharmacists to refuse to dispense abortion meds

http://drugtopics.modernmedicine.com/drug-topics/news/bill-would-allow-pharmacists-refuse-dispense-abortion-meds?page=0,0

A New Mexico state legislative committee has added a provision to an antiabortion measure that would allow pharmacists the right to not dispense abortion medication based on personal and religious beliefs.

The bill bans abortions after 20 weeks of gestation. It was recently  passed by New Mexico’s House Judiciary Committee, but has not yet been voted upon by the entire state legislature. It is sponsored by state Rep. Yvette Herrell, a Republican from Otero.

Pharmacist sues Walgreens over Plan-B firing

“There’s lots of reasons our organization opposes this bill,” Steve Allen, a lobbyist with the American Civil Liberties Union of New Mexico, reportedly told legislators. “But one aspect particularly troubling is the expanded religious exemption.”

Current New Mexico law permits hospitals to refuse to perform abortions based on religious exemptions. However, this recently proposed late term abortion ban stipulates that “any pharmacist or any person under direction of a pharmacist” can refuse to dispense medicine that results in “the termination of a pregnancy.” 

“New Mexico is known as the late-term abortion capitol of the nation. … It’s an opportunity to speak for the unborn,” Rep. Herrell said.

State Rep. Brian Egolf, D-Santa Fe, said the pharmacist provision included in the bill goes too far. “I think this bill does much more than raise the issues addressed by its supporters. The extent and reach of this is vastly broader than I have heard anyone discuss it at all,” he said.

Egolf contends that the provision would allow a pharmacist to not dispense the morning-after pill to a woman on the first day of her pregnancy.

Dale Tinker, executive director of the New Mexico Pharmacists Association, said pharmacists already have the legal discretion to not dispense medications.  “[Our organization] encourages pharmacists to use professional judgment regarding decisions to not fill medications based on appropriate and quality health care,” Tinker said. “Our position is that pharmacists must be allowed to make their own professional judgment call regarding proper dispensing of prescription medications.”